HIGHLIGHTS
- who: Koji Iinuma and collaborators from the Department of Urology, Gifu University Graduate School of Medicine, Gifu, Japan have published the Article: Efficacy and Safety of Cabozantinib in Patients with Advanced or Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Cohort Study, in the Journal: Biomedicines 2022, 3172 of /2022/
- what: A multicenter retrospective study was conducted to evaluate the efficacy and safety of cabozantinib in patients with advanced or metastatic renal cell carcinoma (mRCC). This study has an inherent potential for bias, with diagnostic and therapeutic variations among the institutions.
- how: The authors . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.